PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
An Act To Increase the Effectiveness of Opioid Addiction Therapy
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §3174-SS, as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.
Sec. 2. 22 MRSA §3174-UU, sub-§7, ¶D, as amended by PL 2013, c. 368, Pt. AAAAA, §1, is further amended to read:
 
D. A MaineCare member for whom MaineCare reimbursement for opioid drugs for the treatment of addiction is restricted by limits applicable to methadone and a MaineCare member who is receiving buprenorphine and naloxone combination drugs for the treatment of addiction; and
 
SUMMARY
This bill repeals the 24-month limit on MaineCare coverage or reimbursement for buprenorphine and naloxone combination drugs, also known as Suboxone, for the treatment of addiction to opioids.